Search

Author/Creator Larson, Sarah

1. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study. Issue 3 (23rd February 2020)

Authors:
Shah, Neil P.; García-Gutiérrez, Valentín; Jiménez-Velasco, Antonio; Larson, Sarah; Saussele, Susanne; Rea, Delphine; Mahon, François-Xavier; Levy, Moshe Yair; Gómez-Casares, María Teresa; Pane, Fabrizio; Nicolini, Franck-Emmanuel; Mauro, Michael J.; Sy, Oumar; Martin-Regueira, Patricia; Lipton, ...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 3(2020)
Page Start:
650
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma. Issue 11 (2nd November 2018)

Authors:
Chari, Ajai; Larson, Sarah; Holkova, Beata; Cornell, Robert F.; Gasparetto, Cristina; Karanes, Chatchada; Matous, Jeffrey V.; Niesvizky, Ruben; Valent, Jason; Lunning, Matthew; Usmani, Saad Z.; Anderson, Larry D.; Chang, Lipo; Lee, Yihua; Pak, Yvonne; Salman, Zeena; Graef, Thorsten; Bilotti, Eliz...
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 11(2018)
Page Start:
2588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗